MedPath

Effect of local application of Glycyrrhiza glabra and eucalyptus extract for the prevention of Mucositis

Phase 3
Conditions
Oral Mucositis.
Stomatitis and related lesions
Registration Number
IRCT20190415043279N4
Lead Sponsor
Sanandaj University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Head and neck carcinoma
Full awareness
Oral mucosal health

Exclusion Criteria

History of allergy to medicinal plants
High blood pressure
Diabetes
Autoimmune diseases
Cardiovascular disease
Neutropenia
The presence of mucosal lesions in the mouth
Previous history of radiotherapy and chemotherapy
Chronic liver diseases
Active collagen vascular disease
Non-use of drugs; alcohol; cigarettes

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of oral mucositis. Timepoint: The beginning of the intervention, every week continuously, the end of the intervention, one week after the end of the intervention. Method of measurement: Clinical examination by the dentists and filling standardized physician judged mucositis grading forms.;The need for painkillers during the course of treatment. Timepoint: During the course of treatment. Method of measurement: Check list.;Need for intravenous nutrition during the course of treatment. Timepoint: During the course of treatment. Method of measurement: Check list.;Weight loss during the course of treatment. Timepoint: During the course of treatment. Method of measurement: Check list.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath